Supplementary Table 1 from RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer
Amanda J. Compadre(Washington University in St. Louis), Mary M. Mullen(Cancer Research Center)
Cited by 0
Related Papers
Pediatric Pulmonary Hypertension
|Circulation|2015|1.1k
Supplementary Table 1 from RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer
|Unknown|2023|0
Supplementary Table 1 from RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer
|Unknown|2023|0
Supplementary Table 1 from RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer
|Unknown|2023|0
Targeting the COP9 signalosome overcomes platinum resistance in ovarian cancer through two distinct genome stability mechanisms
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0